Anavex Life Sciences Corp (AVXL)

[La Flaca]

point taken - about 75%?

AVXL submitted information that IMO mitigates potential bias: MRI, biomarkers, and OLE data that is independent of dropout rates. imaging and biomarker data and OLE data. All of this information independenly confirms efficacy. Risk/benefit analysis doesn't seem that tough direct CHMP to make the right decision for patients, Doc. Perfection can't be the enemy of the good here. We're talking about people's lives!